(1)
Influence of the Immune System on the Successful Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Acervo Saúde 2026, 26 (1), e22317. https://doi.org/10.25248/reas.e22317.2026.